🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 89% of ingredients have research evidence
A Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

7.8 Gram(s) Serving Size
30 Servings
Other Combinations Product Type
89% Evidence Coverage

Supplement Facts — Evidence Check

35 mg (175% DV)
✅ 2.5× RDA — within safe limits 📚 193 studies (Tier A: 5, B: 63)
RDA 14mg This product: 35mg UL 35mg
2 mg (100% DV)
✅ 1.5× RDA — within safe limits 📚 113 studies (Tier A: 3, B: 35)
RDA 1.3mg This product: 2mg UL 100mg
800 mcg (200% DV)
✅ 2.0× RDA — within safe limits 📚 225 studies (Tier A: 10, B: 105)
RDA 0.4mg This product: 0.8mg UL 1.0mg
25 mcg (420% DV)
📊 10.4× RDA — above typical dose 📚 138 studies (Tier A: 1, B: 44)
RDA 0.0024mg This product: 0.025mg
60 mg (15% DV)
📊 Market median: 4002.0mg (1 products) 📚 20 studies (Tier A: 0, B: 2)
This product: 60mg
1600 mg
📊 Market median: 1500.0mg (104 products) 📚 21 studies (Tier A: 0, B: 2)
This product: 1600mg
📊 Market median: 5.0mg (298 products) 📚 701 studies (Tier A: 5, B: 123)
This product: 1250mg
📊 Market median: 4002.0mg (1 products) 📚 20 studies (Tier A: 0, B: 2)
This product: 750mg
ENGN(R) Mind-to-Muscle Matrix Proprietary Blend
2.21 Gram(s)

Other Ingredients

Natural and Artificial flavor Malic Acid Tartaric Acid Sucralose Silica Acesulfame Potassium FD&C Red #40

Label Claims — Verification

All Other
Structure/Function
All Other (97% of products) Structure/Function (86% of products) Nutrient (36% of products)

Target Groups

Adult (18 - 50 Years)

Product Information

📋 Directions for Use

SUGGESTED USE: As a dietary supplement, take 1 scoop with 8 oz. (236 mL) of cold water 15-30 minutes before training. To avoid sleeplessness, do not take within 4 hours of sleep.

⚠️ Warnings & Precautions

Warnings: Not for use by those with pre-existing medical conditions or taking any medications, those under the age of 18, women that are contemplating pregnancy, pregnant, nursing or those that are caffeine, niacin, or beta-alanine sensitive.

Discontinue use and consult a healthcare professional if you experience any adverse reaction to this product.

Keep out of reach of all children.

Warnings: Not for use by those with pre-existing medical conditions or taking any medications, those under the age of 18, women that are contemplating pregnancy, pregnant, nursing or those that are caffeine, niacin, or beta-alanine sensitive. Consult a physician prior to using this product if you are taking any prescription or over-the-counter medications or supplements. Do not use this product if you are at risk or are being treated for any medical condition including, but not limited to: high or low blood pressure; cardiac arrhythmia; stroke; heart, liver, kidney or thyroid disease; seizure disorder; psychiatric disease; diabetes; difficulty urinating due to prostate enlargement or if you are taking a MAO inhibitor.

Do not exceed recommended serving size or suggested use for any reason.

Additional Information

This product is manufactured in a GMP compliant facility.

NATURALLY AND ARTIFICIALLY FLAVORED

FACEBOOK.com/EVLsports YOUTUBE.com/EVLsports INSTAGRAM.com/EVLsports TWITTER.com/EVLsports # We want to see your EVL side: # EVL

{Chart} PEAK PERFORMANCE STACK PRODUCTS PRE-WORKOUT DURING WORKOUT POST-WORKOUT ENGN(TM) 1-2 servings 15-30 minutes A-10(TM) AMINO MATRIX 1 serving 1 serving RE-BLD(TM) 1 serving immediately GLU+(TM) L-GLUTAMINE ANTIOXIDANTS 1 serving

- INTENSE ENERGY - EXPLOSIVE POWER - AMPLIFIED PUMPS

Fruit Punch

MADE IN THE USA

EVL(R)

- INTENSE ENERGY - EXPLOSIVE POWER - AMPLIFIED PUMPS - EXPLOSIVE POWER 30 servings

Product Details

DSLD Entry Date 2014-05-23
Product Type Other Combinations
Form Powder
DSLD ID 33286
Data Updated 2026-04-11

Research Evidence

241 Research Sources
55 Avg Quality Score
113 Meta Analysis
75 Systematic Review
32 Rct
11 Clinical Trial
3 Other
3 Regulatory Source
1 Cochrane Review
1 Narrative Review
1 Openfda Safety
A Niacin for primary and secondary prevention of cardiovascular events
Meta Analysis The Cochrane database of systematic reviews 2017
A Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases
Meta Analysis BMJ (Clinical research ed.) 2013
A Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients
Meta Analysis BMJ (Clinical research ed.) 2014
A A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk
Meta Analysis Nature medicine 2024
A Meta-analysis and imputation refines the association of 15q25 with smoking quantity
Meta Analysis Nature genetics 2010
A Genome-wide meta-analyses identify multiple loci associated with smoking behavior
Meta Analysis Nature genetics 2010
A Antidepressants for smoking cessation
Meta Analysis The Cochrane database of systematic reviews 2014
A Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne
Meta Analysis The Cochrane database of systematic reviews 2020
B Assessment of the Role of Niacin in Managing Cardiovascular Disease Outcomes: A Systematic Review and Meta-analysis
Meta Analysis JAMA network open 2019
B Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis
Meta Analysis JAMA 2016
View all evidence for Niacin →

Compare Similar Products

View all Niacin products →